OrthAlign
Private Company
Total funding raised: $50M
Overview
OrthAlign is a commercial-stage private company specializing in handheld surgical navigation systems for total and partial knee and hip replacements. The company has carved out a strategic niche by targeting the high-growth ASC segment with its portable, cost-effective Lantern technology, which avoids the complexity and capital expense of large robotic systems. Led by a seasoned management team with deep experience in medtech commercialization and M&A, OrthAlign is expanding its platform's surgical indications and approach support. Its primary challenge is competing in a crowded orthopedic navigation and robotics market dominated by larger players with broader portfolios and greater sales resources.
Technology Platform
Handheld, computer-assisted surgical navigation platform (Lantern) for precise alignment in hip and knee arthroplasty. Designed as portable, single-use instrument technology that does not require pre-operative imaging or large capital equipment.
Funding History
4Opportunities
Risk Factors
Competitive Landscape
OrthAlign competes in the orthopedic computer-assisted surgery and robotics market, which is dominated by large players like Stryker (Mako), Zimmer Biomet (Rosa), Johnson & Johnson (Velys), and Smith & Nephew. Its primary competitive differentiation is its handheld, low-capital cost model focused on alignment, as opposed to larger robotic systems that offer bone preparation but at a significantly higher cost and footprint.